iScience Raises $20.5 Million
iScience Interventional Inc., a Menlo Park, Calif.-based developer of microcatheter technology for the treatment of ophthalmologic conditions like glaucoma and age-related macular degeneration, has raised $20.5 million in Series F funding. Affinity Capital Management led the round, and was joined by Johnson & Johnson Development Corp., L Capital Partners and Clarian Health Ventures. Return backers included Prism VentureWorks, Three Arch Ventures, DeNovo Ventures and Asset Management Co. Piper Jaffray & Co. served as a placement agent.
21 April 2009•3 mins read
